Search

Maythem M Saeed

from Novato, CA
Age ~73

Maythem Saeed Phones & Addresses

  • 70 Pinto Ln, Novato, CA 94947 (415) 892-0518
  • 622 Plum St, Novato, CA 94945 (415) 892-0518
  • Santa Cruz, CA
  • South San Francisco, CA
  • San Francisco, CA
  • Marina, CA

Publications

Us Patents

Technique To Monitor Drug Delivery Noninvasively In Vivo

View page
US Patent:
6468505, Oct 22, 2002
Filed:
Oct 24, 2000
Appl. No.:
09/696352
Inventors:
Philipp Lang - San Francisco CA
Olivier Meyer - Strasbourg, FR
Michael F. Wendland - Benicia CA
Maythem Saeed - Novato CA
Assignee:
Philipp Lang - Lexington MA
International Classification:
A61B 5055
US Classification:
424 9321, 424450
Abstract:
The present invention relates to the field of diagnostic imaging and more specifically to the field of monitoring drug delivery using non-invasive imaging techniques. The present invention provides for imaging agents and compositions useful for NMR, computed tomography, scintigraphy, PET and any other type of imaging where the imaging agent can be carried by liposomes or other lipid based vehicles, such as micelles or suspended lipid aggregates.

Method

View page
US Patent:
20020090341, Jul 11, 2002
Filed:
Oct 12, 2001
Appl. No.:
09/975317
Inventors:
Alan Watson - Malvern PA, US
Michael Wendland - Benicia CA, US
Per Jynge - Trondheim, NO
Jan Karlsson - Cardiff, GB
Heidi Brurok - Oslo, NO
Pal Rongved - Oslo, NO
Maythem Saeed - Novato CA, US
Assignee:
NYCOMED IMAGING AS
International Classification:
A61K049/00
US Classification:
424/009360
Abstract:
The invention provides a method of detecting myocardial ischemia in a human or a non-human body, said method comprising administering to said body a physiologically acceptable manganese complex or salt thereof, subjecting said body to a magnetic resonance imaging procedure capable of generating images with time intervals of less than 0.5 seconds and thereafter providing a series of images of the myocardium of said body whereby to identify regions of abnormal blood flow. The method in accordance with the invention is of use not only in detecting myocardial ischemia, but also in discriminating between reversibly and irreversibly injured myocardial tissues, thereby providing important information about myocardial viability, e.g. during or following a severe heart attack or coronary occlusion. The method of the invention also provides an effective means of monitoring reperfusion of the myocardium.

Magnetic Resonance Imaging Technique For Tissue Characterization

View page
US Patent:
56717415, Sep 30, 1997
Filed:
Aug 4, 1995
Appl. No.:
8/511286
Inventors:
Philipp Lang - San Francisco CA
Michael Wendland - Benicia CA
Maythem Saeed - Novato CA
Alexander Gindele - San Francisco CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61B 505
US Classification:
1286532
Abstract:
An in vivo diagnostic method for differentiating normal from diseased tissue is described, using diffusion-weighted magnetic resonance imaging (MRI). Differences in molecular diffusion between viable and necrotic tissue, and normal and diseased tissue, are measured using diffusion-weighted MRI techniques to evaluate the success of a medical treatment regimen.
Maythem M Saeed from Novato, CA, age ~73 Get Report